Bio Green Med Solution financials
$0.8800−2.60%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Quarter | Q2 '26 Jun 30 | Q1 '26 Mar 31 | Q4 '25 Dec 31 | Q3 '25 Sep 30 |
|---|---|---|---|---|
| Revenue | $336.0K | $778.0K | $666.0K | $81.0K |
| Gross profit | $79.0K | $143.0K | $121.0K | $17.0K |
| Gross margin | 23.5% | 18.4% | 18.2% | 21.0% |
| Operating income | -$418.0K | -$246.0K | -$1.1M | -$992.0K |
| Net income | -$425.0K | -$217.0K | -$10.2M | -$2.5M |
| Net margin | −126.5% | −27.9% | −1527.0% | −3090.1% |
| Diluted EPS | $-0.08 | $-0.04 | $-1.99 | $-1.31 |
| EBITDA | -$418.0K | -$245.0K | -$1.1M | -$992.0K |
| Operating cash flow | -$352.0K | -$278.0K | -$33.0K | -$434.0K |
| Free cash flow | -$352.0K | -$279.0K | -$33.0K | -$434.0K |
| Diluted shares | 5.6M | 5.5M | 5.1M | 1.9M |
Balance sheet
| Period end | Jun 30 | Mar 31 | Dec 31 | Sep 30 |
|---|---|---|---|---|
| Cash & equivalents | $3.8M | $3.3M | $3.5M | $3.8M |
| Short-term investments | $0.00 | $0.00 | $0.00 | $0.00 |
| Total debt | $0.00 | $0.00 | $0.00 | $0.00 |
| Total assets | $7.9M | $7.6M | $8.2M | $8.2M |
| Total liabilities | $694.0K | $804.0K | $1.3M | $1.1M |
| Shareholders' equity | $7.2M | $6.8M | $6.8M | $7.1M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology